Tractional Retinal Detachment Medication

Updated: Sep 20, 2018
  • Author: Lihteh Wu, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print

Medication Summary

TRDs are considered to be surgical diseases. However, experimental drugs have been used in numerous protocols to try to prevent PVR at different stages of the disease process. Among the drugs studied are heparin and its low molecular weight derivatives, corticosteroids and nonsteroidal anti-inflammatory agents, antimetabolites, and retinoic acid. Most of these agents have been shown to reduce retinal proliferation. However, such issues as drug toxicity, drug delivery, and drug duration of action remain without an ideal solution.